The changing landscape of home dialysis in the United States

Current Opinion in Nephrology and Hypertension

Volumn 23, Issue 6, 2014, Pages 586-591

  Rivara, Matthew B ^a   Mehrotra, Rajnish ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

End stage renal disease; Health policy; Home hemodialysis; Peritoneal dialysis

Indexed keywords

CLINICAL EVALUATION; COST EFFECTIVENESS ANALYSIS; END STAGE RENAL DISEASE; ETHNIC DIFFERENCE; HEALTH CARE UTILIZATION; HOME DIALYSIS; MEDICARE; OUTCOME ASSESSMENT; PATIENT CARE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROSPECTIVE PAYMENT; REVIEW; UNITED STATES; CLINICAL PRACTICE; ECONOMICS; HUMAN; KIDNEY FAILURE, CHRONIC; TREATMENT OUTCOME; TRENDS; UTILIZATION;

HEMODIALYSIS, HOME; HUMANS; KIDNEY FAILURE, CHRONIC; MEDICARE; PERITONEAL DIALYSIS; PRACTICE PATTERNS, PHYSICIANS'; PROSPECTIVE PAYMENT SYSTEM; TREATMENT OUTCOME; UNITED STATES;

EID: 84927620737     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0000000000000066     Document Type: Review

References (31)

1. U.S. Renal Data System. USRDS 2013 Annual Data Report: atlas of chronic kidney disease and end stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA; 2013.
2. Johansen KL, Zhang R, Huang Y, et al. Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a USRDS study. Kidney Int 2009; 76:984-990.
3. Mehrotra R, Chiu Y, Kalantar-Zadeh K, et al. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med 2011; 171:110-118.
4. Pauly RP, Maximova K, Coppens J, et al., CAN-SLEEP Collaborative Group. Patient and technique survival among a Canadian multicenter nocturnal home hemodialysis cohort. Clin J Am Soc Nephrol 2010; 5:1815-1820.
5. Weinhandl ED, Liu J, Gilbertson DT, et al. Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. J Am Soc Nephrol 2012; 23:895-904.
6. Weinhandl ED, Foley RN, Gilbertson DT, et al. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol 2010; 21:499-506.
7. Tina Shih Y-C, Guo A, Just PM, Mujais S. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients. Kidney Int 2005; 68:319-329.
8. Centers for Medicare & Medicaid Services (CMS), HHS. Medicare program; end-stage renal disease prospective payment system. Final rule. Fed Regist 2010; 75:49029-49214.
9. Mendelssohn DC, Mujais SK, Soroka SD, et al. A prospective evaluation of renal replacement therapy modality eligibility. Nephrol Dial Transplant 2009; 24:555-561.
10. Mehrotra R, Marsh D, Vonesh E, et al. Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis. Kidney Int 2005; 68:378-390.
11. Lacson E Jr, Wang W, DeVries C, et al. Effects of a nationwide predialysis educational program on modality choice, vascular access, and patient outcomes. Am J Kidney Dis 2011; 58:235-242.
12. Maaroufi A, Fafin C, Mougel S, et al. Patients' preferences regarding choice of end-stage renal disease treatment options. Am J Nephrol 2013; 37:359-369.
13. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int Suppl 2006; 103:S3-S11.
14. Ghaffari A, Kalantar-Zadeh K, Lee J, et al. PD first: peritoneal dialysis as the default transition to dialysis therapy. Semin Dial 2013; 26:706-713.
15. Yeates K, Zhu N, Vonesh E, et al. Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant 2012; 27:3568-3575.
16. Juergensen E, Wuerth D, Finkelstein SH, et al. Hemodialysis and peritoneal dialysis: patients' assessment of their satisfaction with therapy and the impact of the therapy on their lives. Clin J Am SocNephrol 2006; 1:1191-1196.
17. Brown EA, Johansson L, Farrington K, et al. Broadening options for long-term dialysis in the elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients. Nephrol Dial Transplant 2010; 25:3755-3763.
18. Tennankore KK, Chan CT, Curran SP. Intensive home haemodialysis: benefits and barriers. Nat Rev Nephrol 2012; 8:515-522.
19. Kohn OF, Coe FL, Ing TS. Solute kinetics with short-daily home hemodialysis using slow dialysate flow rate. Hemodial Int 2010; 14:39-46.
20. Culleton BF, Walsh M, Klarenbach SW, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 2007; 298:1291-1299.
21. Rocco MV, Lockridge RS, Beck GJ, et al. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int 2011; 80:1080-1091.
22. Kjellstrand C, Buoncristiani U, Ting G, et al. Survival with short-daily hemodialysis: association of time, site, and dose of dialysis. Hemodial Int 2010; 14:464-470.
23. Nesrallah GE, Lindsay RM, Cuerden MS, et al. Intensive hemodialysis associates with improved survival compared with conventional hemodialysis. J Am Soc Nephrol 2012; 23:696-705.
24. Lee H, Manns B, Taub K, et al. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis 2002; 40:611-622.
25. Hornberger J, Hirth RA. Financial implications of choice of dialysis type of the revised Medicare payment system: an economic analysis. Am J Kidney Dis 2012; 60:280-287.
26. Young BA, Chan C, Blagg C, et al. How to overcome barriers and establish a successful home HD program. Clin J Am Soc Nephrol 2012; 7:2023-2032.
27. Berns JS. A survey-based evaluation of self-perceived competency after nephrology fellowship training. Clin J Am Soc Nephrol 2010; 5:490-496.
28. Duong U, Kalantar-Zadeh K, Molnar MZ, et al. Mortality associated with dose response of erythropoiesis-stimulating agents in hemodialysis versus peritoneal dialysis patients. Am J Nephrol 2012; 35:198-208.
29. Ornt DB, Larive B, Rastogi A, et al., Frequent Hemodialysis Network Trial Group. Impact of frequent hemodialysis on anemia management: results from the Frequent Hemodialysis Network (FHN) Trials. Nephrol Dial Transplant 2013; 28:1888-1898.
30. Centers for Medicare & Medicaid Services (CMS), HHS. Medicare program; end-stage renal disease prospective payment system, quality incentive program, and durable medical equipment, prosthetics, orthotics, and supplies. Fed Regist 2013; 78:72155-72253.
31. Hirth RA, Turenne MN, Wheeler JRC, et al. The Initial impact of Medicare's new prospective payment system for kidney dialysis. Am J Kidney Dis 2013; 62:662-669.